These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11508771)

  • 1. Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.
    Frangione-Beebe M; Rose RT; Kaumaya PT; Schwendeman SP
    J Microencapsul; 2001; 18(5):663-77. PubMed ID: 11508771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.
    Frangione-Beebe M; Albrecht B; Dakappagari N; Rose RT; Brooks CL; Schwendeman SP; Lairmore MD; Kaumaya PT
    Vaccine; 2000 Dec; 19(9-10):1068-81. PubMed ID: 11137241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
    Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
    Blanco D; Alonso MJ
    Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles.
    Partidos CD; Vohra P; Jones D; Farrar G; Steward MW
    J Immunol Methods; 1997 Aug; 206(1-2):143-51. PubMed ID: 9328577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.
    Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP
    J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
    Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E
    Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
    Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
    J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
    Cho SW; Song SH; Choi YW
    Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres.
    Meinel L; Illi OE; Zapf J; Malfanti M; Peter Merkle H; Gander B
    J Control Release; 2001 Jan; 70(1-2):193-202. PubMed ID: 11166419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.
    Men Y; Gander B; Merkle HP; Corradin G
    Vaccine; 1996 Oct; 14(15):1442-50. PubMed ID: 8994320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation.
    Carrasquillo KG; Carro JC; Alejandro A; Toro DD; Griebenow K
    J Pharm Pharmacol; 2001 Jan; 53(1):115-20. PubMed ID: 11206185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
    Morlock M; Kissel T; Li YX; Koll H; Winter G
    J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres.
    Igartua M; Hernández RM; Esquisabel A; Gascón AR; Calvo MB; Pedraz JL
    J Control Release; 1998 Dec; 56(1-3):63-73. PubMed ID: 9801430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization.
    Marazuela EG; Prado N; Moro E; Fernández-García H; Villalba M; Rodríguez R; Batanero E
    Clin Exp Allergy; 2008 Mar; 38(3):520-8. PubMed ID: 18205856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D,L-lactide-co-glycolide) implants.
    Kang J; Schwendeman SP
    Biomaterials; 2002 Jan; 23(1):239-45. PubMed ID: 11762843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein.
    Carrasquillo KG; Stanley AM; Aponte-Carro JC; De Jésus P; Costantino HR; Bosques CJ; Griebenow K
    J Control Release; 2001 Oct; 76(3):199-208. PubMed ID: 11578736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.